These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3877113)

  • 61. Azygos venous blood flow while fasting, postprandially, and after endoscopic variceal ligation, measured by magnetic resonance imaging.
    Sugano S; Yamamoto K; Takamura N; Momiyama K; Watanabe M; Ishii K
    J Gastroenterol; 1999 Jun; 34(3):310-4. PubMed ID: 10433004
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hyposensitivity to vasopressin in patients with hepatitis B-related cirrhosis during acute variceal hemorrhage.
    Tsai YT; Lee FY; Lin HC; Lee SD; Hsia HC; Lin WJ; Wang SS; Lay CS; Lai KH; Lo KJ
    Hepatology; 1991 Mar; 13(3):407-12. PubMed ID: 1999311
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Emergency shunt for variceal bleeding.
    Rikkers LF
    J Am Coll Surg; 1995 Mar; 180(3):337-9. PubMed ID: 7874345
    [No Abstract]   [Full Text] [Related]  

  • 64. [Endoscopic sclerotization of esophageal varices and nitrates in the treatment of portal hypertension with bleeding esophageal varices].
    Drazná E; Jedlicka J; Petrtýl J; Cervinka J; Vrana J
    Sb Lek; 1991 Oct; 93(9-10):301-7. PubMed ID: 1821463
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of metoclopramide on portal blood flow in patients with liver cirrhosis, measured by the pulsed Doppler system.
    Ljubicić N
    Scand J Gastroenterol; 1990 Oct; 25(10):1004-9. PubMed ID: 2263872
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Complications of cirrhosis. I. Portal hypertension.
    Bosch J; García-Pagán JC
    J Hepatol; 2000; 32(1 Suppl):141-56. PubMed ID: 10728801
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical vs haemodynamic response to drugs in portal hypertension.
    McCormick PA; Patch D; Greenslade L; Chin J; McIntyre N; Burroughs AK
    J Hepatol; 1998 Jun; 28(6):1015-9. PubMed ID: 9672178
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The role of hemodynamic measurements in portosystemic shunt surgery.
    Reynolds TB
    Arch Surg; 1974 Mar; 108(3):276-81. PubMed ID: 4360343
    [No Abstract]   [Full Text] [Related]  

  • 69. Role of endoscopy in primary prophylaxis for esophageal variceal bleeding.
    Albillos A; Peñas B; Zamora J
    Clin Liver Dis; 2010 May; 14(2):231-50. PubMed ID: 20682232
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interrelationship between insulin resistance and portal haemodynamic abnormality in cirrhosis.
    Maruyama H; Kobayashi K; Kiyono S; Yokosuka O
    Int J Med Sci; 2017; 14(3):240-245. PubMed ID: 28367084
    [No Abstract]   [Full Text] [Related]  

  • 71. Theoretical and practical considerations in the treatment of portal hypertension secondary to hepatic cirrhosis.
    Bizer LS
    Am Surg; 1984 Oct; 50(10):524-9. PubMed ID: 6385791
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Transient elastography as a predictor of oesophageal varices in patients with liver cirrhosis].
    Pár G; Trosits A; Pakodi F; Szabó I; Czimmer J; Illés A; Gódi S; Bajor J; Sarlós P; Kenyeres P; Miseta A; Vincze A; Pár A
    Orv Hetil; 2014 Feb; 155(7):270-6. PubMed ID: 24509356
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Natural history of a randomized trial comparing distal spleno-renal shunt with endoscopic sclerotherapy in the prevention of variceal rebleeding: a lesson from the past.
    Santambrogio R; Opocher E; Costa M; Bruno S; Ceretti AP; Spina GP
    World J Gastroenterol; 2006 Oct; 12(39):6331-8. PubMed ID: 17072957
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis.
    Lebrec D; De Fleury P; Rueff B; Nahum H; Benhamou JP
    Gastroenterology; 1980 Dec; 79(6):1139-44. PubMed ID: 6969201
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long-term effects of distal splenorenal shunt on hepatic hemodynamics and liver function in patients with cirrhosis: importance of reversal of portal blood flow.
    Lacy AM; Navasa M; Gilabert R; Brú C; García-Pagán JC; García-Valdecasas JC; Grande L; Feu F; Fuster J; Terés J
    Hepatology; 1992 Apr; 15(4):616-22. PubMed ID: 1551639
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Methods to evaluate portal hypertension.
    Lebrec D
    Gastroenterol Clin North Am; 1992 Mar; 21(1):41-59. PubMed ID: 1568777
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Commentary on an abstract. Effects of metoclopramide and domperidone on azygous venous blood flow in patients with cirrhosis and portal hypertension].
    Sauerbruch T
    Z Gastroenterol; 1987 Sep; 25(9):612-3. PubMed ID: 3673147
    [No Abstract]   [Full Text] [Related]  

  • 78. Azygos blood flow: phase contrast quantitation in volunteers and patients with portal hypertension pre- and postintrahepatic shunt placement.
    Debatin JF; Zahner B; Meyenberger C; Romanowski B; Schöpke W; Marincek B; Fuchs WA
    Hepatology; 1996 Nov; 24(5):1109-15. PubMed ID: 8903384
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The azygos circulation time and mechanism of varix rupture in portal hypertension.
    Hassab MA
    Surgery; 1970 Sep; 68(3):442-9. PubMed ID: 4918423
    [No Abstract]   [Full Text] [Related]  

  • 80. Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial.
    Pollo-Flores P; Soldan M; Santos UC; Kunz DG; Mattos DE; da Silva AC; Marchiori RC; Rezende GF
    Dig Liver Dis; 2015 Nov; 47(11):957-63. PubMed ID: 26321186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.